Your browser doesn't support javascript.
loading
ASO Visual Abstract: Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-institutional, Prospective Study (UROCCR Study 82).
Tabourin, Thomas; Pinar, Ugo; Parra, Jerome; Vaessen, Christophe; Bensalah, Charles-Karim; Audenet, Francois; Bigot, Pierre; Champy, Cecile; Olivier, Jonathan; Bruyere, Franck; Doumerc, Nicolas; Paparel, Philippe; Parier, Bastien; Nouhaud, Francois-Xavier; Durand, Xavier; Lang, Herve; Branger, Nicolas; Long, Jean Alexandre; Durand, Matthieu; Waeckel, Thibaut; Charles, Thomas; Cussenot, Olivier; Xylinas, Evanguelos; Boissier, Romain; Tambwe, Ricky; Patard, Jean Jacques; Bernhard, Jean Christophe; Roupret, Morgan.
Afiliação
  • Tabourin T; GRC 5, Predictive Onco-Urology, APHP, Hôpital Pitié-Salpêtrière, Urology, Sorbonne University, F-75013, Paris, France.
  • Pinar U; GRC 5, Predictive Onco-Urology, APHP, Hôpital Pitié-Salpêtrière, Urology, Sorbonne University, F-75013, Paris, France.
  • Parra J; GRC 5, Predictive Onco-Urology, APHP, Hôpital Pitié-Salpêtrière, Urology, Sorbonne University, F-75013, Paris, France.
  • Vaessen C; GRC 5, Predictive Onco-Urology, APHP, Hôpital Pitié-Salpêtrière, Urology, Sorbonne University, F-75013, Paris, France.
  • Bensalah CK; Department of Urology, University Hospital of Rennes, Rennes, France.
  • Audenet F; Department of Urology,  AP-HP Centre, Hôpital Européen Georges Pompidou, Université de Paris, Paris, France.
  • Bigot P; Department of Urology, University Hospital of Angers, Angers, France.
  • Champy C; Department of Urology, APHP, Henri Mondor University Hospital, Créteil, France.
  • Olivier J; Department of Urology, University Hospital of Lille, Lille, France.
  • Bruyere F; Department of Urology, University Hospital of Tours, Tours, France.
  • Doumerc N; Department of Urology, University Hospital of Toulouse, Toulouse, France.
  • Paparel P; Department of Urology, University Hospital of Lyon, Lyon, France.
  • Parier B; Department of Urology, APHP, Bicetre University Hospital, Paris Saclay University, Le Kremlin Bicetre, France.
  • Nouhaud FX; Department of Urology, University Hospital of Rouen, Rouen, France.
  • Durand X; Department of Urology, Hospital Saint Joseph, Paris, France.
  • Lang H; Department of Urology, University Hospital of Strasbourg, Strasbourg, France.
  • Branger N; Department of Urology, Institut Paoli-Calmettes, Marseille, France.
  • Long JA; Department of Urology, University Hospital of Grenoble, Grenoble, France.
  • Durand M; Department of Urology, University Hospital of Nice, Nice, France.
  • Waeckel T; Department of Urology, University Hospital of Caen, Caen, France.
  • Charles T; Department of Urology, University Hospital of Poitiers, Poitiers, France.
  • Cussenot O; GRC n°5, AP-HP, Tenon Hospital, Sorbonne Université, 75020, Paris, France.
  • Xylinas E; Urology Department, Bichat-Claude Bernard Hospital, Assistance-Publique Hôpitaux de Paris, Paris University, Paris, France.
  • Boissier R; Department of Urology, University Hospital of Marseille, Marseille, France.
  • Tambwe R; Department of Urology, University Hospital of Reims, Reims, France.
  • Patard JJ; Department of Urology, Hospital of Mont-de-Marsan, Mont-de-Marsan, France.
  • Bernhard JC; Department of Urology, University Hospital of Bordeaux, Bordeaux, France.
  • Roupret M; GRC 5, Predictive Onco-Urology, APHP, Hôpital Pitié-Salpêtrière, Urology, Sorbonne University, F-75013, Paris, France. morgan.roupret@aphp.fr.
Ann Surg Oncol ; 29(11): 7229-7230, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35989394

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article